本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bicara Therapeutics

15.51
+1.6912.23%
盤後15.510.00000.00%17:52 EDT
成交量:117.58萬
成交額:1,807.42萬
市值:8.46億
市盈率:-3.83
高:16.22
開:14.10
低:13.66
收:13.82
資料載入中...
2025/03/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/26

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/26

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/18

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/11

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/03

SEC問詢函

Form CORRESP - Correspondence
2024/09/03

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/28

SEC問詢函

Form CORRESP - Correspondence